Loading candles…
Incorporated in 1979, Shivalik Rasayan Ltd operates in India as a manufacturer focused on agrochemicals and Active Pharmaceutical Ingredients (APIs). The company serves the agrochemical and pharmaceutical sectors by producing key products including Dimethoate Technical and Malathion, where it holds the positions of the largest and second-largest producer in India, respectively. In addition to agrochemicals, Shivalik Rasayan has developed a growing presence in the pharmaceutical API segment, particularly in oncology and non-oncology therapeutic areas. The company has evolved from primarily an agrochemical producer into an integrated entity with significant operations in specialty chemicals and life sciences, reflecting an expanded portfolio that includes both agrochemical and pharmaceutical API production.
This page is a live market overview for SHIVALIK RASAYAN LIMITED (SHIVALIK) on the NSE. As a listed security, SHIVALIK RASAYAN LIMITED is tracked in the Chemicals segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for SHIVALIK before placing trades on tick2trade.
As of the latest feed, SHIVALIK last traded at ₹433 on NSE, up ₹16.1 (3.86%) from the previous close of ₹416.9. Today's session range is ₹423.35 – ₹436.9, against a 52-week band of ₹206.4 – ₹491.25. Traded volume today stands at 1.43L shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for SHIVALIK in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether SHIVALIK is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for SHIVALIK RASAYAN LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in SHIVALIK. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated SHIVALIK option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 14 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend | 27 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 13 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 14 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 12 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 30 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.